We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Article |

Ketoconazole Therapy for AIDS Patients With Disseminated Histoplasmosis-Reply

L. Joseph Wheat, MD
Arch Intern Med. 1985;145(12):2272. doi:10.1001/archinte.1985.00360120144046.
Text Size: A A A
Published online


In Reply.  —Ketoconazole failed to prevent clinical relapse with disseminated histoplasmosis in the patient with AIDS described by Drs Gustafson and Henson. Their patient also failed amphotericin B therapy, presumably because of the severe immune incompetence associated with AIDS. Based on the encouraging experience of Dr Bonner and co-workers, I have used ketoconazole to prevent relapse in two patients with AIDS and histoplasmosis.1 Both patients subsequently suffered a relapse. The first patient, a 29-year-old male drug addict, developed recurrent disseminated histoplasmosis manifested as fever and chronic meningitis while receiving 400 mg/day of ketoconazole. Histoplasma capsulatum was isolated from the cerebrospinal fluid, but blood and bone marrow cultures were negative. His meningitis initially responded to amphotericin B therapy, but he eventually died with persistent central nervous system histoplasmosis. Neither ketoconazole nor amphotericin B cross the blood-brain barrier well, perhaps explaining the patient's relapse with chronic meningitis. The second patient, a


Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

First Page Preview

View Large
First page PDF preview





Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

0 Citations

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.